BioCentury
ARTICLE | Clinical News

Lidakol n-docosanol 10 percent cream: LDAKA began one of two Phase III trials

August 5, 1996 7:00 AM UTC

Lidak Pharmaceuticals (LDAKA), La Jolla, Calif. Product: Lidakol n-docosanol 10 percent cream Indication: Recurrent oral herpes (cold sores) Status: LDAKA began one of two Phase III trials, with the s...